Core Viewpoint - Oracle plans to raise up to another $25 billion this year through either equity or equity-linked issuances [1] Group 1 - The company is looking to increase its capital through significant fundraising efforts [1] - The planned amount of $25 billion indicates a strong confidence in market conditions and future growth prospects [1]

Core Viewpoint - Ares Management Corporation has facilitated $1.6 billion in debt financing to support the merger of Suave Brands Company and Elida Beauty, resulting in the formation of Evermark, LLC, a new leading global platform for personal care brands [1][3]. Group 1: Ares Management Corporation - Ares Management Corporation is a prominent global alternative investment manager with over $595 billion in assets under management as of September 30, 2025, offering investment solutions across various asset classes including credit, real estate, private equity, and infrastructure [4]. - The company emphasizes its commitment to providing flexible capital that supports businesses and creates value for investors and communities [4]. Group 2: Evermark, LLC - Evermark, LLC is established as a personal care platform that combines the legacy of Suave Brands and Elida Beauty, featuring a portfolio of well-known brands such as Suave, ChapStick, Q-tips, and others [2][5]. - The company aims to drive sustainable growth through brand-focused leadership, operational discipline, and long-term investment strategies [5]. Group 3: Yellow Wood Partners - Yellow Wood Partners is a consumer-focused private equity firm that invests in both founder-owned and legacy consumer brands, managing over 40 household global brands [6]. - The firm employs a unique investment and operating strategy called Consumer Operating DNA® to unlock brand value and facilitate growth [6].

TORONTO and GLIL YAM, Israel, Jan. 26, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced that it has raised a total of US$2,171,660.40 in debt financings from an arm's length third party (the "Lender") in order to manage the Company's current liquidity requirements. First Note Pursuant to a note purchase agreement between the Company and Lender dated January 7, 2026 (the "First Note Purch ...

Core Viewpoint - Abcourt Mines Inc. has entered into a binding term sheet with Glencore AG for a senior debt financing of up to US$30 million and an accompanying offtake agreement, aimed at strengthening liquidity and funding exploration activities [1][6]. Financing Details - The financing will be provided in two tranches: Tranche A of US$18.125 million available on the Closing Date, and Tranche B of up to US$11.875 million available at the Corporation's option between December 1, 2026, and January 31, 2027 [4]. - Proceeds will be used to repay higher-cost debt, fund exploration and capital expenditures at the Flordin project, and provide additional working capital [4]. - The financing matures 60 months after the Closing Date and bears interest at a rate of 1-Month SOFR plus 2.5% per annum, payable monthly after the first anniversary [4]. - Glencore will receive 68,905,000 warrants, each exercisable for one common share at C$0.15 for the first 36 months, and C$0.20 thereafter for the remaining term [4]. Offtake Agreement Details - Glencore will purchase 100% of the gold and silver dore production from the Sleeping Giant Mine for a minimum term of six years, with an aggregate delivery of 150,000 ounces of gold [4]. - After the initial term, Glencore will have a right of first refusal for additional purchases [4]. - Pricing for the offtake will be based on the average official LBMA prices for gold and silver [4][9]. - Glencore will also purchase all mineral products from the Flordin-Cartwright property for eight years after commercial production begins [4]. Company Overview - Abcourt Mines Inc. is a Canadian gold development company with properties in northwestern Québec, including the Sleeping Giant Mine and Mill, and the Flordin property [7].

Core Insights - Treace Medical Concepts has secured a new five-year $175 million senior secured loan arrangement to enhance its financial strength and flexibility [1][2] - The financing includes $60 million in term loans, $65 million in additional term loan availability, and a $50 million revolving credit facility [1][2] - The company aims to use the proceeds to prepay existing loans and strengthen its balance sheet while expanding its market presence [2][3] Financial Details - The new loan arrangement has a maturity date of five years, with an annual interest rate tied to the SOFR, subject to a minimum of 3% [2][4] - The term loan allows for 48 months of interest-only payments, extendable by an additional 12 months [2] - Following the refinancing, the company has approximately $165 million in total liquidity, including cash and unused credit facility availability [3] Company Overview - Treace Medical Concepts focuses on advancing surgical treatments for bunions and related midfoot deformities, addressing a significant market need with an estimated 67 million affected Americans [8] - The company has developed the patented Lapiplasty3D Bunion Correction System, which aims to correct bunion deformities in three dimensions [8] - Treace also offers various surgical systems and digital solutions to support surgeons and patients, enhancing its competitive position in the market [8]

WHAT THAT COULD HOLD FOR DEALMAKING. PAUL GRIGGS IS THE US SENIOR PARTNER AT PWC AND JOINS US WITH MUCH MORE ON THAT REPORT. PAUL, THANKS FOR BEING HERE, FRANK. >> THANKS FOR HAVING ME.>> REALLY FASCINATING REPORT. SO WHY DON'T WE START OFF WHERE WE KIND OF HAD YOU RIGHT THERE WITH WARNER BROS. DISCOVERY.PARAMOUNT. WHAT DOES THAT SIGNAL. THE FACT THAT WE'RE SEEING BIDDING WARS AND ALSO WANT TO KIND OF THROW IN THE IDEA WE'RE SEEING MORE DEBT FINANCING USED FOR DEALS.DOES THAT SIGNAL THAT WE MIGHT BE AT SOME ...

Core Viewpoint - Oracle's stock experienced its worst trading day since 2001, closing 11% lower after Q2 revenues missed estimates, leading to a significant widening of its CDS spread [1][2] Financial Performance - Oracle reported total revenue of $16.1 billion for fiscal Q2 2026, a 14% increase year-over-year, although it fell short of the estimated $16.21 billion [5] - The cloud segment generated approximately $8 billion in revenue, reflecting a year-over-year growth of 34% [5] - Earnings per share for the quarter were $2.26, up 54% from the previous year, exceeding the consensus estimate of $1.64 [6] Debt and Capital Expenditure - The company has a substantial debt load exceeding $100 billion and is projected to increase its capital expenditure forecast to about $50 billion in fiscal year 2026, up from $35 billion [2] - The widening CDS spread indicates increased costs for raising debt, which could impact future fundraising efforts [1][2] Market Sentiment and Future Outlook - Despite the recent stock decline, Oracle's year-to-date performance remains positive with a nearly 12% increase, raising questions about the sustainability of its fundamentals [4] - The company's historical performance shows a mixed record in meeting earnings estimates over the past eight quarters, which may affect investor sentiment moving forward [6]

Let's get to see Modi for more on the widening bond yields for Oracle and some of these other hyperscalers which appears to be hurting the stock. >> Yeah, and it's clear Sarah that the market is becoming just more aware of how these hyperscalers are spending money especially when it comes to debt as it pertains to Oracle. The key question is whether the company can raise mountains of new debt while holding on to its investment grade credit rating currently at tripleB the lowest of all the hyperscalers.Last ...

The financing offered by the trio of lenders is a bridge loan, which will come in the form of investment-grade secured debt and non-investment-grade unsecured components, denominated in dollars and euros to capture as much liquidity as possible, according to people familiar with the matter. This unusual hybrid structure is expected to offer investors more yield than is typically seen in an investment-grade deal, the people said.Bankers have seen this movie before. The money provided by Bank of America Corp. ...

Core Viewpoint - Lumen Technologies, through its subsidiary Level 3 Financing, is increasing its offering of Senior Notes to $1.25 billion, which is a $500 million increase from the previously announced amount [1][4]. Group 1: Offering Details - Level 3 Financing is selling $1.25 billion aggregate principal amount of 8.500% Senior Notes due January 15, 2036, priced at 100.000% of their aggregate principal amount [1][2]. - The Notes will be fully guaranteed by Level 3 Parent, LLC, and certain unregulated subsidiaries on an unsubordinated and unsecured basis [2]. - The offering is expected to be completed on December 23, 2025, subject to customary closing conditions [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used to purchase Existing Second Lien Notes and to pay related fees and expenses, with any remaining funds allocated for general corporate purposes [3]. - Level 3 Financing is conducting cash tender offers to purchase outstanding notes, increasing the aggregate purchase price to $1.5 billion from the previously announced $1.0 billion [4]. Group 3: Regulatory Information - The Notes will not be registered under the Securities Act of 1933 and are being offered only to qualified institutional buyers and non-U.S. persons [5]. - This press release does not constitute an offer to sell or solicit offers to buy the Notes or Existing Second Lien Notes in any jurisdiction where such actions would be unlawful [6]. Group 4: Company Overview - Lumen Technologies aims to unleash digital potential by connecting people, data, and applications, focusing on business growth and AI capabilities [7].